Evaluate the long term efficacy and safety of Hymovis® in the symptomatic treatment of knee osteoarthritis

A multi-centre, open label, long-term follow up study to evaluate the benefits of a new viscoelastic hydrogel (Hymovis^®) in the treatment of knee osteoarthritis.

Article specifications

This clinical study was published in 2016 in Journal of Eur Rev Med Pharmacol Sci (IF 2014:1.575) by Italian specialists. The aim of this study was to evaluate the long term efficacy and safety of Hymovis® in the symptomatic treatment of knee osteoarthritis.

 

Result

Results from this study confirm that Hymovis® alleviate the knee pain since the first treatment cycle. The patients treated with two cycles of intra-articular injections of Hymovis® have a progressive pain reduction that is maintained up to one year after the treatment start with improve of all the scores considered in this study. Hymovis® is effective and safe in symptomatic treatment of painful knee OA.